Literature DB >> 16157300

Protein arginine methyltransferase 6 specifically methylates the nonhistone chromatin protein HMGA1a.

Tina Branscombe Miranda1, Kristofor J Webb, Dale D Edberg, Raymond Reeves, Steven Clarke.   

Abstract

The HMGA family proteins HMGA1a and HMGA1b are nuclear nonhistone species implicated in a wide range of cellular processes including inducible gene transcription, modulation of chromosome structure through nucleosome and chromosome remodeling, and neoplastic transformation. HMGA proteins are highly modified, and changes in their phosphorylation states have been correlated with the phase of the cell cycle and changes in their transcriptional activity. HMGA1a is also methylated in the first DNA-binding AT-hook at Arg25 and other sites, although the enzyme or enzymes responsible have not been identified. We demonstrate here that a GST fusion of protein arginine methyltransferase 6 (PRMT6) specifically methylates full-length recombinant HMGA1a protein in vitro. Although GST fusions of PRMT1 and PRMT3 were also capable of methylating the full-length HMGA1a polypeptide, they recognize its proteolytic degradation products much better. GST fusions of PRMT4 or PRMT7 were unable to methylate the full-length protein or its degradation products. We conclude that PRMT6 is a good candidate for the endogenous enzyme responsible for HGMA1a methylation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157300     DOI: 10.1016/j.bbrc.2005.08.179

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

Review 1.  High mobility group proteins and their post-translational modifications.

Authors:  Qingchun Zhang; Yinsheng Wang
Journal:  Biochim Biophys Acta       Date:  2008-05-10

Review 2.  Protein and DNA modifications: evolutionary imprints of bacterial biochemical diversification and geochemistry on the provenance of eukaryotic epigenetics.

Authors:  L Aravind; A Maxwell Burroughs; Dapeng Zhang; Lakshminarayan M Iyer
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-07-01       Impact factor: 10.005

Review 3.  Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond.

Authors:  Daniela Boehm; Melanie Ott
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

4.  Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming ω-NG-monomethylated arginine residues.

Authors:  Cecilia I Zurita-Lopez; Troy Sandberg; Ryan Kelly; Steven G Clarke
Journal:  J Biol Chem       Date:  2012-01-12       Impact factor: 5.157

5.  PELP1 oncogenic functions involve alternative splicing via PRMT6.

Authors:  Monica Mann; Yi Zou; Yidong Chen; Darrell Brann; Ratna Vadlamudi
Journal:  Mol Oncol       Date:  2013-12-30       Impact factor: 6.603

Review 6.  The dynamics of HMG protein-chromatin interactions in living cells.

Authors:  Gabi Gerlitz; Robert Hock; Tetsuya Ueda; Michael Bustin
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

7.  Genetic evidence for partial redundancy between the arginine methyltransferases CARM1 and PRMT6.

Authors:  Donghang Cheng; Guozhen Gao; Alessandra Di Lorenzo; Sandrine Jayne; Michael O Hottiger; Stephane Richard; Mark T Bedford
Journal:  J Biol Chem       Date:  2020-10-02       Impact factor: 5.157

8.  Thrombospondin-1 is a transcriptional repression target of PRMT6.

Authors:  Jonathan Michaud-Levesque; Stéphane Richard
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

9.  A quantitative study on the in vitro and in vivo acetylation of high mobility group A1 proteins.

Authors:  Qingchun Zhang; Kangling Zhang; Yan Zou; Avi Perna; Yinsheng Wang
Journal:  J Am Soc Mass Spectrom       Date:  2007-06-13       Impact factor: 3.109

10.  Protein arginine methyltransferase 6 regulates multiple aspects of gene expression.

Authors:  Matthew J Harrison; Yue Hang Tang; Dennis H Dowhan
Journal:  Nucleic Acids Res       Date:  2010-01-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.